After t the 3-month intervention, the inflammatory state of the RA patients in the SF + MTX group improved, the levels of the proinflammatory cytokine IL-6 decreased, and the levels of the anti-inflammatory cytokine IL-10 increased in the serum (Figure 6B). The gene discussed is IL6; the disease is rheumatoid arthritis.